Sign in

NCT03611881CompletedPhase 4

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening

Source: ClinicalTrials.gov · Last updated 28 Oct 2024

Brief summary (registry, in English)

This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be randomly assigned to receive these interventions: (1) smoking cessation counseling support by telephone or videoconferencing (short duration vs. long duration); (2) nicotine patch treatment (NRT) (short vs.long duration); (3) counselor-facilitated referral (vs. no referral) to an online resource to connect smokers to a community-based social service resources.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
642 (actual)
First submitted
27 Jul 2018
Start date
1 Apr 2019
Primary completion date
31 Jan 2024
Lead sponsor
Massachusetts General Hospital
Diseases
Lung cancer
NCT number
NCT03611881

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 642
  • From 1 Apr 2019 to the primary completion date, 31 Jan 2024
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unable to give informed consent due to psychiatric or cognitive impairment as determined in consultation with study PI or treating clinician.

Other

  • Undergoing lung CT as part of a diagnostic or abnormal follow-up evaluation.
  • No access to a telephone or cannot communicate by telephone.

Who the study is looking for

  • Scheduled to undergo LDCT-LCS at a participating Mass General Brigham Health Care System LCS site
  • Speak English or Spanish.
  • Current smokers: smoked a cigarette, even a puff, in the last 30 days.
  • Medicare coverage requirement (age 50-80 years, 20+ pack/years).
  • Residing within the USA.

Age in the registry: 50 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Brigham & Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Brigham & Women's Faulkner Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Newton-Wellesley Hospital
Coordinator of this site? Confirm its status
NewtonUnited StatesUnknown status
Martha's Vineyard Hospital
Coordinator of this site? Confirm its status
Oak BluffsUnited StatesUnknown status
Salem Hospital
Coordinator of this site? Confirm its status
SalemUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.